Shares in IP Group plc have risen 14.31% in early trading on Monday (as of 1pm) after the investment firm said it could receive future revenue linked to a series of obesity drug candidates being developed by US MedTech Metsera Inc. Metsera was recently acquired by Pfizer in a deal worth up to $7.3 billion. … Continue reading IP Group shares fly on back of Metsera & Pfizer news